Clinical Benefits, Costs, and Cost-Effectiveness of Neonatal Intensive Care in Mexico
Background:
Neonatal intensive care improves survival, but is associated with high costs and disability amongst survivors. Recent health reform in Mexico launched a new subsidized insurance program, necessitating informed choices on the different interventions that might be covered by the program, including neonatal intensive care. The purpose of this study was to estimate the clinical outcomes, costs, and cost-effectiveness of neonatal intensive care in Mexico.
Methods and Findings:
A cost-effectiveness analysis was conducted using a decision analytic model of health and economic outcomes following preterm birth. Model parameters governing health outcomes were estimated from Mexican vital registration and hospital discharge databases, supplemented with meta-analyses and systematic reviews from the published literature. Costs were estimated on the basis of data provided by the Ministry of Health in Mexico and World Health Organization price lists, supplemented with published studies from other countries as needed. The model estimated changes in clinical outcomes, life expectancy, disability-free life expectancy, lifetime costs, disability-adjusted life years (DALYs), and incremental cost-effectiveness ratios (ICERs) for neonatal intensive care compared to no intensive care. Uncertainty around the results was characterized using one-way sensitivity analyses and a multivariate probabilistic sensitivity analysis. In the base-case analysis, neonatal intensive care for infants born at 24–26, 27–29, and 30–33 weeks gestational age prolonged life expectancy by 28, 43, and 34 years and averted 9, 15, and 12 DALYs, at incremental costs per infant of US$11,400, US$9,500, and US$3,000, respectively, compared to an alternative of no intensive care. The ICERs of neonatal intensive care at 24–26, 27–29, and 30–33 weeks were US$1,200, US$650, and US$240, per DALY averted, respectively. The findings were robust to variation in parameter values over wide ranges in sensitivity analyses.
Conclusions:
Incremental cost-effectiveness ratios for neonatal intensive care imply very high value for money on the basis of conventional benchmarks for cost-effectiveness analysis.
: Please see later in the article for the Editors' Summary
Vyšlo v časopise:
Clinical Benefits, Costs, and Cost-Effectiveness of Neonatal Intensive Care in Mexico. PLoS Med 7(12): e32767. doi:10.1371/journal.pmed.1000379
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000379
Souhrn
Background:
Neonatal intensive care improves survival, but is associated with high costs and disability amongst survivors. Recent health reform in Mexico launched a new subsidized insurance program, necessitating informed choices on the different interventions that might be covered by the program, including neonatal intensive care. The purpose of this study was to estimate the clinical outcomes, costs, and cost-effectiveness of neonatal intensive care in Mexico.
Methods and Findings:
A cost-effectiveness analysis was conducted using a decision analytic model of health and economic outcomes following preterm birth. Model parameters governing health outcomes were estimated from Mexican vital registration and hospital discharge databases, supplemented with meta-analyses and systematic reviews from the published literature. Costs were estimated on the basis of data provided by the Ministry of Health in Mexico and World Health Organization price lists, supplemented with published studies from other countries as needed. The model estimated changes in clinical outcomes, life expectancy, disability-free life expectancy, lifetime costs, disability-adjusted life years (DALYs), and incremental cost-effectiveness ratios (ICERs) for neonatal intensive care compared to no intensive care. Uncertainty around the results was characterized using one-way sensitivity analyses and a multivariate probabilistic sensitivity analysis. In the base-case analysis, neonatal intensive care for infants born at 24–26, 27–29, and 30–33 weeks gestational age prolonged life expectancy by 28, 43, and 34 years and averted 9, 15, and 12 DALYs, at incremental costs per infant of US$11,400, US$9,500, and US$3,000, respectively, compared to an alternative of no intensive care. The ICERs of neonatal intensive care at 24–26, 27–29, and 30–33 weeks were US$1,200, US$650, and US$240, per DALY averted, respectively. The findings were robust to variation in parameter values over wide ranges in sensitivity analyses.
Conclusions:
Incremental cost-effectiveness ratios for neonatal intensive care imply very high value for money on the basis of conventional benchmarks for cost-effectiveness analysis.
: Please see later in the article for the Editors' Summary
Zdroje
1. RichardsonDK
GrayJE
GortmakerSL
GoldmannDA
PursleyDM
1998 Declining severity adjusted mortality: evidence of improving neonatal intensive care. Pediatrics 102 893 899
2. DoyleLW
2004 Evaluation of neonatal intensive care for extremely low birth weight infants in Victoria over two decades: I. Effectiveness. Pediatrics 113 505 509
3. ShanmugasundaramR
PadmapriyaE
ShyamalaJ
1998 Cost of neonatal intensive care. Indian J Pediatr 65 249 255
4. ZupancicJA
RichardsonDK
LeeK
McCormickMC
2000 Economics of prematurity in the era of managed care. Clin Perinatol 27 483 497
5. DoyleLW
2004 Evaluation of neonatal intensive care for extremely low birth weight infants in Victoria over two decades: II. Efficiency. Pediatrics 113 510 514
6. RogowskiJ
1998 Cost-effectiveness of care for very low birth weight infants. Pediatrics 102 35 43
7. SaigalS
BurrowsE
StoskopfBL
RosenbaumPL
StreinerD
2000 Impact of extreme prematurity on families of adolescent children. J Pediatr 137 701 706
8. WatsonRS
2003 Prematurity-associated costs: more than just surfactant. Pediatr Crit Care Med 4 256 257
9. XuK
EvansDB
KawabataK
ZeramdiniR
KlavusJ
2003 Household catastrophic health expenditure: a multicountry analysis. Lancet 362 111 117
10. VohrBR
WrightLL
DusickAM
MeleL
VerterJ
2000 Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 105 1216 1226
11. StraughnHK
GoldenbergRL
TolosaJE
DalyS
de CodesJ
2003 Birthweight-specific neonatal mortality in developing countries and obstetric practices. Int J Gynaecol Obstet 80 71 78
12. FrenkJ
Gonzalez-PierE
Gomez-DantesO
LezanaMA
KnaulFM
2006 Comprehensive reform to improve health system performance in Mexico. Lancet 368 1524 1534
13. Gonzalez-PierE
Gutierrez-DelgadoC
StevensG
Barraza-LlorensM
Porras-CondeyR
2006 Priority setting for health interventions in Mexico's System of Social Protection in Health. Lancet 368 1608 1618
14. Tan-Torres EdejerT
BaltussenRM
AdamT
HutubessyR
AcharyaA
2003 Making choices in health: WHO guide to cost-effectiveness analysis. Geneva, Switzerland World Health Organization 312
15. KramerMS
PlattRW
WenSW
JosephKS
AllenA
2001 A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108 e35
16. Ceron-MirelesP
HarlowSD
Sanchez-CarrilloCI
1996 The risk of prematurity and small-for-gestational-age birth in Mexico City: the effects of working conditions and antenatal leave. Am J Public Health 86 825 831
17. LeeKS
KimBI
KhoshnoodB
HsiehHL
ChenTJ
1995 Outcome of very low birth weight infants in industrialized countries: 1947–1987. Am J Epidemiol 141 1188 1193
18. ChaseHC
1972 A study of infant mortality from linked records: comparison of neonatal mortality from two cohort studies. Rockville (Maryland) US Department of Health, Education and Welfare. National Center for Health Statistics (HSM) 72 1056
19. Consejo Nacional de Población Proyecciones de la población de México 2005–2050 Available: http://www.conapo.gob.mx/. Accessed 19 October 2010
20. SingerRB
StraussD
ShavelleR
1998 Comparative mortality in cerebral palsy patients in California, 1980–1996. J Insur Med 30 240 246
21. StraussD
EymanRK
1996 Mortality of people with mental retardation in California with and without Down syndrome, 1986–1991. Am J Ment Retard 100 643 653
22. EscobarGJ
LittenbergB
PetittiDB
1991 Outcome among surviving very low birthweight infants: a meta-analysis. Arch Dis Child 66 204 211
23. LorenzJM
WoolieverDE
JettonJR
PanethN
1998 A quantitative review of mortality and developmental disability in extremely premature newborns. Arch Pediatr Adolesc Med 152 425 435
24. LorenzJM
2001 The outcome of extreme prematurity. Semin Perinatol 25 348 359
25. RobertsG
AndersonPJ
DoyleLW
Victorian Infant Collaborative Study Group 2009 Neurosensory disabilities at school age in geographic cohorts of extremely low birth weight children born between the 1970s and the 1990s. J Pediatr 154 829 834
26. SaigalS
DoyleLW
2008 An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 371 261 269
27. CarrollAE
DownsSM
2009 Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. J Pediatr 155 21 25, 25
28. World Health Organization CHOosing Interventions that are Cost-Effective (WHO-CHOICE). Health State Valuations. Available: http://who.int/choice/demography/health_valuations/en/index.html. Accessed 19 October 2010
29. LemonsJA
BauerCR
OhW
KoronesSB
PapileLA
2001 Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 107 e1
30. LeeSK
McMillanDD
OhlssonA
PendrayM
SynnesA
2000 Variations in practice and outcomes of the Canadian NICU Network 1996–7. Pediatrics 106 1070 1079
31. AdamT
EvansDB
MurrayCJ
2003 Econometric estimation of country-specific hospital costs. Cost Eff Resour Alloc 1 3
32. ZupancicJA
RichardsonDK
2002 Characterization of neonatal personnel time inputs and prediction from clinical variables—a time and motion study. J Perinatol 22 658 663
33. YostCC
SollRF
2000 Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev CD001456
34. Osiris Collaborative Group 1992 Early versus delayed neonatal administration of a synthetic surfactant—the judgment of OSIRIS. Lancet 340 1363 1369
35. EscobarGJ
McCormickMC
ZupancicJAF
Coleman-PhoxK
ArmstrongMA
2006 Unstudied infants: outcomes of moderately premature infants in the neonatal intensive care unit. Arch Dis Child - Fetal and Neonatal Edition 91 F238 F244
36. NagataE
BritoAS
MatsuoT
2002 Nosocomial infections in a neonatal intensive care unit: incidence and risk factors. Am J Infect Control 30 26 31
37. Pessoa-SilvaCL
RichtmannR
CalilR
SantosRM
CostaML
2004 Healthcare-associated infections among neonates in Brazil. Infect Control Hosp Epidemiol 25 772 777
38. PayneNR
CarpenterJH
BadgerGJ
HorbarJD
RogowskiJ
2004 Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 114 348 355
39. UnderwoodMA
DanielsenB
GilbertWM
2007 Cost, causes and rates of rehospitalization of preterm infants. J Perinatol 27 614 619
40. HoneycuttA
DunlapL
ChenH
Al HomsiG
2000 The cost of developmental disabilities. Research Triangle Park (North Carolina) Research Triangle Institute
41. HoneycuttAA
GrosseSD
DunlapLJ
SchedelDE
ChenH
2003 Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment.
AltmanB
BarnarttS
HedershotG
LarsonS
Using survey data to study disability: results from the National Health Interview Survey on disability London Elsevier 207 228
42. HutubessyR
ChisholmD
EdejerT
for W-C 2003 Generalized cost-effectiveness analysis for national-level priority-setting in the health sector. Cost Eff Resour Alloc 1 8
43. DoubiletP
BeggCB
WeinsteinMC
BraunP
McNeilBJ
1985 Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach. Med Decis Making 5 157 177
44. World Bank Data. Indicators. GDP per capita (current US$). Available: http://data.worldbank.org/indicator/NY.GDP.PCAP.CD. Accessed 19 October 2010
45. UNICEF Millenium Development Goals. Available: www.unicef.org/mdg. Accessed 19 October 2010
46. LawnJE
CousensS
DarmstadtGL
PaulV
MartinesJ
2004 Why are 4 million newborn babies dying every year? Lancet 364 2020
47. DarmstadtGL
BhuttaZA
CousensS
AdamT
WalkerN
2005 Evidence-based, cost-effective interventions: how many newborn babies can we save? Lancet 365 977 988
48. NarendranV
DonovanEF
HoathSB
AkinbiHT
SteichenJJ
2003 Early bubble CPAP and outcomes in ELBW preterm infants. J Perinatol 23 195 199
49. KoyamaiboleL
KadoJ
QovuJD
ColquhounS
DukeT
2006 An evaluation of bubble-CPAP in a neonatal unit in a developing country: effective respiratory support that can be applied by nurses. Journal of Tropical Pediatrics 52 249 253
50. LawnJE
Mwansa-KambafwileJ
HortaBL
BarrosFC
CousensS
2010 ‘Kangaroo mother care’ to prevent neonatal deaths due to preterm birth complications. Int J Epidemiol 39 Suppl 1 i144 i154
51. AskieLM
Henderson-SmartDJ
KoH
2009 Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants. Cochrane Database Syst Rev CD001077
52. MoralesY
SchanlerRJ
2007 Human milk and clinical outcomes in VLBW infants: how compelling is the evidence of benefit? Semin Perinatol 31 83 88
53. SollRF
2008 Heat loss prevention in neonates. J Perinatol 28 Suppl 1 S57 S59
54. SaigalS
StoskopfB
BoyleM
PanethN
PinelliJ
2007 Comparison of current health, functional limitations, and health care use of young adults who were born with extremely low birth weight and normal birth weight. Pediatrics 119 e562 e573
55. SaigalS
StreinerD
2009 Socio-economic achievements of individuals born very preterm at the age of 27 to 29 years. Dev Med Child Neurol 51 848 850
56. SaigalS
StoskopfBL
FeenyD
FurlongW
BurrowsE
1999 Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA 281 1991 1997
57. VerripsE
VogelsT
SaigalS
WolkeD
MeyerR
2008 Health-related quality of life for extremely low birth weight adolescents in Canada, Germany, and the Netherlands. Pediatrics 122 556 561
58. CutlerDM
McClellanM
2001 Is technological change in medicine worth it? Health Affairs 20 11 29
59. CheahIGS
SoosaiAP
WongSL
LimTO
2004 Cost-effectiveness analysis of Malaysian neonatal intensive care units. J Perinatol 25 47 53
60. International Monetary Fund GDP, deflator. Available: http://www.econstats.com/weo/V005.htm. Accessed 19 October 2010
61. GilbertC
RahiJ
EcksteinM
O'SullivanJ
FosterA
1997 Retinopathy of prematurity in middle-income countries. Lancet 350 12 14
62. GilbertC
FielderA
GordilloL
QuinnG
SemigliaR
2005 Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 115 e518 e525
63. World Health Organization WHO Director-General's Roundtable with Women Leaders on Millennium Development Goal 5. Country Profiles. Mexico. Available: http://www.who.int/making_pregnancy_safer/events/2008/mdg5/countries/cp_mexico_19_09_09.pdf. Accessed 19 October 2010
64. RiosJM
Tufino-OlivaresE
Reza-LopezS
SaninLH
Levario-CarrilloM
2008 Birthweight percentiles by gestational age and gender for children in the North of Mexico. Paediatr Perinat Epidemiol 22 188 194
65. LozanoR
SolizP
GakidouE
bbott-KlafterJ
FeehanDM
2006 Benchmarking of performance of Mexican states with effective coverage. Lancet 368 1729 1741
66. Acevedo-GarciaD
SoobaderMJ
BerkmanLF
2005 The differential effect of foreign-born status on low birth weight by race/ethnicity and education. Pediatrics 115 e20 e30
67. Martinez-CruzCF
PoblanoA
Fernandez-CarroceraLA
Jimenez-QuirozR
Tuyu-TorresN
2006 Association between intelligence quotient scores and extremely low birth weight in school-age children. Archives of Medical Research 37 639 645
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 12
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study
- Participatory Epidemiology: Use of Mobile Phones for Community-Based Health Reporting
- Scaling Up the 2010 World Health Organization HIV Treatment Guidelines in Resource-Limited Settings: A Model-Based Analysis
- Toward a Consensus on Guiding Principles for Health Systems Strengthening